Clinical Guidelines

Provides general information about telehealth, how to talk with a patient about telehealth options; finding telehealth options through insurance, federally qualified health centers, and other sources; COVID-19 self-assessment tools; a digital telehealth directory and emergency hotlines.

Blog post that provides recommendations for policymakers and insurers to support telehealth use by primary care providers

Provides information about the development and potential uses of the USAUDIT alcohol screening clinical decision support that can be integrated into electronic health record systems and other health information technology to help providers identify adults who should be screened for alcohol use

May 2021, SAMHSA revised certain areas of all five parts of this TIP to bring the content up to date and make it as useful to readers as possible. These changes will help provide readers with the latest information needed to understand medications for opioid use disorder.

This guide focuses on evidence based interventions for the initiation of MAT in EDs, specifically buprenorphine. It provides guidance on developing programs to provide these clinical services, overcoming challenges, and successful implementation strategies.

This guide presents three evidence based practices that engage and improve outcomes for youth and young adults with co-occurring SED/SMI and substance misuse or SUD. These approaches will assist clinicians, behavioral health organizations, primary care providers, schools, insurers, transformation experts, and policy makers to understand, select, and implement evidence-based interventions that support youth and young adult mental health. These include psychosocial interventions, family behavioral therapy, medication, proactive outreach, and use of web-based and other technologies.

This Advisory is based on the SAMHSA's Treatment Improvement Protocol (TIP) 42, Substance Use Disorder Treatment for People With Co-Occurring Disorders. It highlights strategies for counselors and administrators to properly screen, assess, diagnose, and manage the treatment of individuals with CODs.

This guidance publication is intended to support the efforts of states, tribes, and local communities in addressing the needs of pregnant women with opioid use disorders and their infants and families.

This toolkit, informed by interviews with key leaders across several states, examines state policy actions at each of the intercept levels defined in the Sequential Intercept Model framework, and explores opportunities for states to successfully integrate treatment and prevention services across the behavioral health and criminal justice continuum.

This module introduces family support professionals and other service providers to basic information about the importance of medication compliance, and provides an understanding of how pregnant and parenting women being treated for behavioral health or medical conditions may be non-compliant or misuse medications. It prepares service providers to recognize women who may be at risk for noncompliance or misuse of medications, develop a plan for referral, and support women with behavioral health problems or medical condition.